Cognition Therapeutics to Report Fourth Quarter and Year End 2025 Financial Results

Cognition Therapeutics to Report Fourth Quarter and Year End 2025 Financial Results

Conference Call and Live Webcast Scheduled for March 26, 2026 Conference Call and Live Webcast Scheduled for March 26, 2026

PURCHASE, N.Y., March 23, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical-stage company developing product candidates that treat neurodegenerative disorders, (the Com… [+6450 chars]